Transcatheter Aortic Valve Replacement Size to Hit USD 12.92 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Transcatheter Aortic Valve Replacement Market

5.1. COVID-19 Landscape: Transcatheter Aortic Valve Replacement Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Transcatheter Aortic Valve Replacement Market, By Implantation Procedure

8.1. Transcatheter Aortic Valve Replacement Market, by Implantation Procedure

8.1.1. Transfemoral

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Transapical

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Transaortic

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Stainless Steel

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Nitinol

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Cobalt Chromium

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Others

8.1.7.1. Market Revenue and Volume Forecast

Chapter 9. Global Transcatheter Aortic Valve Replacement Market, By Material

9.1. Transcatheter Aortic Valve Replacement Market, by Material

9.1.1. Stainless Steel

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Nitinol

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Cobalt Chromium

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Transcatheter Aortic Valve Replacement Market, By Mechanism

10.1. Transcatheter Aortic Valve Replacement Market, by Mechanism

10.1.1. Balloon-expanding Valve

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Self-expanding Valve

10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global Transcatheter Aortic Valve Replacement Market, By End-Use

11.1. Transcatheter Aortic Valve Replacement Market Revenue and Volume Forecast, by End-Use

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Ambulatory Surgical Centers

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Others

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global Transcatheter Aortic Valve Replacement Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.1.2. Market Revenue and Volume Forecast, by Material

12.1.3. Market Revenue and Volume Forecast, by Mechanism

12.1.4. Market Revenue and Volume Forecast, by End-Use

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.1.5.2. Market Revenue and Volume Forecast, by Material

12.1.5.3. Market Revenue and Volume Forecast, by Mechanism

12.1.5.4. Market Revenue and Volume Forecast, by End-Use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.1.6.2. Market Revenue and Volume Forecast, by Material

12.1.6.3. Market Revenue and Volume Forecast, by Mechanism

12.1.6.4. Market Revenue and Volume Forecast, by End-Use

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.2.2. Market Revenue and Volume Forecast, by Material

12.2.3. Market Revenue and Volume Forecast, by Mechanism

12.2.4. Market Revenue and Volume Forecast, by End-Use

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.2.5.2. Market Revenue and Volume Forecast, by Material

12.2.5.3. Market Revenue and Volume Forecast, by Mechanism

12.2.5.4. Market Revenue and Volume Forecast, by End-Use

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.2.6.2. Market Revenue and Volume Forecast, by Material

12.2.6.3. Market Revenue and Volume Forecast, by Mechanism

12.2.6.4. Market Revenue and Volume Forecast, by End-Use

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.2.7.2. Market Revenue and Volume Forecast, by Material

12.2.7.3. Market Revenue and Volume Forecast, by Mechanism

12.2.7.4. Market Revenue and Volume Forecast, by End-Use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.2.8.2. Market Revenue and Volume Forecast, by Material

12.2.8.3. Market Revenue and Volume Forecast, by Mechanism

12.2.8.4. Market Revenue and Volume Forecast, by End-Use

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.3.2. Market Revenue and Volume Forecast, by Material

12.3.3. Market Revenue and Volume Forecast, by Mechanism

12.3.4. Market Revenue and Volume Forecast, by End-Use

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.3.5.2. Market Revenue and Volume Forecast, by Material

12.3.5.3. Market Revenue and Volume Forecast, by Mechanism

12.3.5.4. Market Revenue and Volume Forecast, by End-Use

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.3.6.2. Market Revenue and Volume Forecast, by Material

12.3.6.3. Market Revenue and Volume Forecast, by Mechanism

12.3.6.4. Market Revenue and Volume Forecast, by End-Use

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.3.7.2. Market Revenue and Volume Forecast, by Material

12.3.7.3. Market Revenue and Volume Forecast, by Mechanism

12.3.7.4. Market Revenue and Volume Forecast, by End-Use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.3.8.2. Market Revenue and Volume Forecast, by Material

12.3.8.3. Market Revenue and Volume Forecast, by Mechanism

12.3.8.4. Market Revenue and Volume Forecast, by End-Use

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.4.2. Market Revenue and Volume Forecast, by Material

12.4.3. Market Revenue and Volume Forecast, by Mechanism

12.4.4. Market Revenue and Volume Forecast, by End-Use

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.4.5.2. Market Revenue and Volume Forecast, by Material

12.4.5.3. Market Revenue and Volume Forecast, by Mechanism

12.4.5.4. Market Revenue and Volume Forecast, by End-Use

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.4.6.2. Market Revenue and Volume Forecast, by Material

12.4.6.3. Market Revenue and Volume Forecast, by Mechanism

12.4.6.4. Market Revenue and Volume Forecast, by End-Use

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.4.7.2. Market Revenue and Volume Forecast, by Material

12.4.7.3. Market Revenue and Volume Forecast, by Mechanism

12.4.7.4. Market Revenue and Volume Forecast, by End-Use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.4.8.2. Market Revenue and Volume Forecast, by Material

12.4.8.3. Market Revenue and Volume Forecast, by Mechanism

12.4.8.4. Market Revenue and Volume Forecast, by End-Use

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.5.2. Market Revenue and Volume Forecast, by Material

12.5.3. Market Revenue and Volume Forecast, by Mechanism

12.5.4. Market Revenue and Volume Forecast, by End-Use

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.5.5.2. Market Revenue and Volume Forecast, by Material

12.5.5.3. Market Revenue and Volume Forecast, by Mechanism

12.5.5.4. Market Revenue and Volume Forecast, by End-Use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Implantation Procedure

12.5.6.2. Market Revenue and Volume Forecast, by Material

12.5.6.3. Market Revenue and Volume Forecast, by Mechanism

12.5.6.4. Market Revenue and Volume Forecast, by End-Use

Chapter 13. Company Profiles

13.1. Medtronic plc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Abbott Laboratories, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Boston Scientific Corporation

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Meril Life Sciences Pvt. Ltd., Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Edwards Lifesciences Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. St. Jude Medical, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. JenaValve Technology, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Bracco SpA

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Transcatheter Technologies GmbH

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The global transcatheter aortic valve replacement market size was exhibited at USD 6.65 billion in 2025 and is expected to increase USD 12.92 billion by 2035.

Answer : The global transcatheter aortic valve replacement market will register growth rate of 6.87% between 2026 and 2035.

Answer : The major players operating in the transcatheter aortic valve replacement market are Medtronic plc, Abbott Laboratories, Inc., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., Inc., Edwards Lifesciences Corporation, St. Jude Medical, Inc., JenaValve Technology, Inc., Bracco SpA, Transcatheter Technologies GmbH, and Others.

Answer : The driving factors of the transcatheter aortic valve replacement market are the growing demand for innovative treatments and the less invasive approach offered by market.

Answer : North America region will lead the global transcatheter aortic valve replacement market during the forecast period 2026 to 2035.